Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Natural Product Research
|
January 20, 2018
<i>In vitro</i> antioxidant potential and <i>in vivo</i> effects of <i>Schinus terebinthifolia</i> Raddi leaf extract in diabetic rats and determination of chemical composition by HPLC-ESI-MS/MS
Camila Cristina Iwanaga, Lilian Dos Anjos Oliveira Ferreira, Karine Zanoli Bernuci, et al.
Molecules (Basel, Switzerland)
|
December 16, 2016
Evaluation of Chemical Composition and Antileishmanial and Antituberculosis Activities of Essential Oils of Piper Species
Karine Zanoli Bernuci, Camila Cristina Iwanaga, Carla Maria Mariano Fernadez-Andrade, et al.
Acta Dermato-Venereologica
|
October 3, 2025
Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations
Niccolo Gori, Alvise Sernicola, Elena Ippoliti, et al.
The Journal of Dermatological Treatment
|
July 4, 2023
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study
Niccolò Gori, Alvise Sernicola, Ersilia Tolino, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
December 4, 2020
Antituberculosis Activities of Lapachol and β-Lapachone in Combination with Other Drugs in Acidic pH
Andressa Lorena Ieque, Hayalla Corrêa de Carvalho, Vanessa Pietrowski Baldin, et al.
Gigascience
|
October 15, 2020
IDseq-An open source cloud-based pipeline and analysis service for metagenomic pathogen detection and monitoring
Katrina L Kalantar, Tiago Carvalho, Charles F A de Bourcy, et al.
Dermatology and Therapy
|
October 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study
Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo, et al.
Clinical and Experimental Dermatology
|
July 9, 2026
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study
Maddalena Napolitano, Giuseppe Lauletta, Marianna Cimmino, et al.
International Journal of Dermatology
|
August 21, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, et al.
Clinical and Experimental Dermatology
|
October 30, 2025
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study
Giuseppe Lauletta, Cataldo Patruno, Luca Potestio, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Natural Product Research
|
January 20, 2018
<i>In vitro</i> antioxidant potential and <i>in vivo</i> effects of <i>Schinus terebinthifolia</i> Raddi leaf extract in diabetic rats and determination of chemical composition by HPLC-ESI-MS/MS
Camila Cristina Iwanaga, Lilian Dos Anjos Oliveira Ferreira, Karine Zanoli Bernuci, et al.
Molecules (Basel, Switzerland)
|
December 16, 2016
Evaluation of Chemical Composition and Antileishmanial and Antituberculosis Activities of Essential Oils of Piper Species
Karine Zanoli Bernuci, Camila Cristina Iwanaga, Carla Maria Mariano Fernadez-Andrade, et al.
Acta Dermato-Venereologica
|
October 3, 2025
Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations
Niccolo Gori, Alvise Sernicola, Elena Ippoliti, et al.
The Journal of Dermatological Treatment
|
July 4, 2023
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study
Niccolò Gori, Alvise Sernicola, Ersilia Tolino, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
December 4, 2020
Antituberculosis Activities of Lapachol and β-Lapachone in Combination with Other Drugs in Acidic pH
Andressa Lorena Ieque, Hayalla Corrêa de Carvalho, Vanessa Pietrowski Baldin, et al.
Gigascience
|
October 15, 2020
IDseq-An open source cloud-based pipeline and analysis service for metagenomic pathogen detection and monitoring
Katrina L Kalantar, Tiago Carvalho, Charles F A de Bourcy, et al.
Dermatology and Therapy
|
October 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study
Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo, et al.
Clinical and Experimental Dermatology
|
July 9, 2026
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study
Maddalena Napolitano, Giuseppe Lauletta, Marianna Cimmino, et al.
International Journal of Dermatology
|
August 21, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, et al.
Clinical and Experimental Dermatology
|
October 30, 2025
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study
Giuseppe Lauletta, Cataldo Patruno, Luca Potestio, et al.
Page
of 7